Ming‐Fang He

1.9k total citations
60 papers, 1.5k citations indexed

About

Ming‐Fang He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ming‐Fang He has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Ming‐Fang He's work include Angiogenesis and VEGF in Cancer (9 papers), Natural Compounds in Disease Treatment (6 papers) and Zebrafish Biomedical Research Applications (4 papers). Ming‐Fang He is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Natural Compounds in Disease Treatment (6 papers) and Zebrafish Biomedical Research Applications (4 papers). Ming‐Fang He collaborates with scholars based in China, United States and Hong Kong. Ming‐Fang He's co-authors include Zhiheng He, Jiaqi Wu, Paul Pui‐Hay But, Lizong Shen, Jing Zhai, Xuequan Yao, Jiajia Shen, Chong-Yong Li, Wei Ge and Lingling Jiang and has published in prestigious journals such as PLoS ONE, Oncogene and Chemosphere.

In The Last Decade

Ming‐Fang He

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming‐Fang He China	21	675	307	245	193	170	60	1.5k
Yingzi Wang China	23	1.2k 1.7×	366 1.2×	221 0.9×	113 0.6×	152 0.9×	92	2.3k
Mahmoud Aghaei Iran	26	1.1k 1.6×	249 0.8×	296 1.2×	184 1.0×	176 1.0×	116	2.0k
Byeong Mo Kim South Korea	26	880 1.3×	218 0.7×	276 1.1×	118 0.6×	108 0.6×	47	1.9k
Varisa Pongrakhananon Thailand	27	1.0k 1.5×	297 1.0×	365 1.5×	273 1.4×	145 0.9×	73	1.9k
Amar Singh India	32	1.2k 1.7×	304 1.0×	284 1.2×	132 0.7×	377 2.2×	115	2.7k
Jia Liu China	31	1.1k 1.6×	348 1.1×	304 1.2×	102 0.5×	133 0.8×	113	2.3k
Xuan Liu China	24	856 1.3×	199 0.6×	254 1.0×	73 0.4×	307 1.8×	68	2.3k
Jian‐Dong Jiang China	30	1.5k 2.2×	365 1.2×	220 0.9×	319 1.7×	140 0.8×	143	3.0k
Tzyh‐Chyuan Hour Taiwan	27	1.2k 1.7×	375 1.2×	311 1.3×	140 0.7×	179 1.1×	73	2.0k

Countries citing papers authored by Ming‐Fang He

Since Specialization

Citations

This map shows the geographic impact of Ming‐Fang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Fang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Fang He more than expected).

Fields of papers citing papers by Ming‐Fang He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Fang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Fang He. The network helps show where Ming‐Fang He may publish in the future.

Co-authorship network of co-authors of Ming‐Fang He

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Fang He. A scholar is included among the top collaborators of Ming‐Fang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Fang He. Ming‐Fang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiang, Jing, et al.. (2025). Mechanism of etoposide resistance in small cell lung cancer and the potential therapeutic options. Medical Oncology. 42(5). 167–167.

Wang, Yanli, et al.. (2025). Folic acid supplementation on congenital heart disease and its dual character. PubMed. 8. 100222–100222.

Yu, Yue, Haiying Lu, Ming‐Fang He, et al.. (2024). Strategic chemical synthesis and application of nanocarriers responsive to the tumor microenvironment. Nano Today. 58. 102421–102421. 26 indexed citations

Hu, Jiangchun, Ling Liang, Ming‐Fang He, & Yongping Lu. (2023). Sensitive and Direct Analysis of Pseudomonas aeruginosa through Self-Primer-Assisted Chain Extension and CRISPR-Cas12a-Based Color Reaction. ACS Omega. 8(38). 34852–34858. 6 indexed citations

Cheng, Yongzhi, et al.. (2023). Anti-inflammatory effects of 6S-5-methyltetrahydrofolate‐calcium on RAW264.7 cells and zebrafish. Life Sciences. 327. 121839–121839. 6 indexed citations

Wu, Jiaqi, Yuyang Liu, Xiangyu Liu, et al.. (2021). Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis. Journal of Experimental & Clinical Cancer Research. 40(1). 371–371. 21 indexed citations

Liu, Yuyang, et al.. (2020). Isoliquiritin promote angiogenesis by recruiting macrophages to improve the healing of zebrafish wounds. Fish & Shellfish Immunology. 100. 238–245. 26 indexed citations

Wu, Jiaqi, et al.. (2020). A systematical comparison of anti-angiogenesis and anti-cancer efficacy of ramucirumab, apatinib, regorafenib and cabozantinib in zebrafish model. Life Sciences. 247. 117402–117402. 31 indexed citations

Wang, Jianli, Xiaohuan Zhang, Qing Zhu, et al.. (2020). Pro-angiogenic activity of Tongnao decoction on HUVECs in vitro and zebrafish in vivo. Journal of Ethnopharmacology. 254. 112737–112737. 8 indexed citations

10.

Wu, Jiaqi, et al.. (2019). Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway. Life Sciences. 235. 116791–116791. 73 indexed citations

11.

Zhai, Jing, Jiajia Shen, Jiaqi Wu, et al.. (2019). Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Letters. 454. 37–43. 206 indexed citations

12.

Li, Chong-Yong, et al.. (2018). Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo. Phytomedicine. 48. 10–20. 11 indexed citations

13.

Wu, Jiaqi, Jing Zhai, Chong-Yong Li, et al.. (2017). Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 160–160. 68 indexed citations

14.

Gong, Guiyi, Lingling Jiang, Wenyuan Liu, et al.. (2017). In vivo toxic effects of 4-methoxy-5-hydroxy-canthin-6-one in zebrafish embryos via copper dyshomeostasis and oxidative stress. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 204. 79–87. 8 indexed citations

15.

Wang, Yingchun, Yinan Wu, Suli Wang, et al.. (2016). Docosahexaenoic Acid Modulates Invasion and Metastasis of Human Ovarian Cancer via Multiple Molecular Pathways. International Journal of Gynecological Cancer. 26(6). 994–1003. 18 indexed citations

16.

Jiang, Lingling, Kang Li, Jian Ren, et al.. (2016). Gambogic acid causes fin developmental defect in zebrafish embryo partially via retinoic acid signaling. Reproductive Toxicology. 63. 161–168. 13 indexed citations

17.

Li, Kang, Lingling Jiang, Jianying Li, et al.. (2016). Developmental toxicity of 2,4-dichlorophenoxyacetic acid in zebrafish embryos. Chemosphere. 171. 40–48. 127 indexed citations

18.

Wang, Jiangnan, Rong Ma, Ashok Sharma, et al.. (2015). Inflammatory Serum Proteins Are Severely Altered in Metastatic Gastric Adenocarcinoma Patients from the Chinese Population. PLoS ONE. 10(4). e0123985–e0123985. 10 indexed citations

19.

He, Zhiheng, Rui Zhou, Ming‐Fang He, et al.. (2010). Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine. 18(6). 470–478. 62 indexed citations

20.

Liang, Zhitao, Ming‐Fang He, Wang‐Fun Fong, Zhi‐Hong Jiang, & Zhongzhen Zhao. (2008). A comparable, chemical and pharmacological analysis of the traditional Chinese medicinal herbs Oldenlandia diffusa and O. corymbosa and a new valuation of their biological potential. Phytomedicine. 15(4). 259–267. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact